Long‐term human IgG treatment improves heart and muscle function in a mouse model of Duchenne muscular dystrophy
Abstract Background Duchenne muscular dystrophy (DMD) is a progressive muscle‐wasting disease caused by mutations in the dystrophin gene, which leads to structural instability of the dystrophin-glycoprotein‐complex with subsequent muscle degeneration. In addition, muscle inflammation has been implic...
Saved in:
Main Authors: | Jana Zschüntzsch (Author), Pia Vanessa Jouvenal (Author), Yaxin Zhang (Author), Florian Klinker (Author), Malte Tiburcy (Author), David Liebetanz (Author), Dörthe Malzahn (Author), Heinrich Brinkmeier (Author), Jens Schmidt (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989) -
Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021) -
Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995) -
Glucocorticoids for Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2013) -
Eteplirsen in the treatment of Duchenne muscular dystrophy
by: Lim KRQ, et al.
Published: (2017)